ReportsImmunology

Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease

See allHide authors and affiliations

Science  30 Jun 2016:
aaf6756
DOI: 10.1126/science.aaf6756

Log in to view full text

Log in through your institution

Log in through your institution

Subjects

Navigate This Article